ArticleBJUI compass2025

Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours.

Nasreen Abdul Aziz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.